Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

Merck Serono asks EMEA to re-think Erbitux rejection

July 30, 2009
Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono

Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …

News

BMS launches cancer website

July 15, 2009
Medical Communications, Sales and Marketing BMS, Cancer, digi

Bristol-Myers Squibb has launched a new website for sufferers of chronic myeloid leukaemia (CML), a cancer of the blood. MyCMLCare.com …

News

Pfizer halts Sutent colon cancer trial

July 2, 2009
Research and Development, Sales and Marketing Cancer, Pfizer, Sutent

Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …

News

Merck Serono breast cancer vaccine enters phase III

June 22, 2009
Research and Development Cancer, Merck Serono, Stimuvax, vaccines

Merck Serono is to begin a global phase III study for its therapeutic cancer vaccine Stimuvax in patients with advanced, …

News

ASCO 2009: advance of the blockbusters

June 18, 2009
Sales and Marketing ASCO, Cancer

Key highlights of the recent American Society of Clinical Oncology's 45th Annual Meeting in Florida saw current blockbusters advance standard …

News

Don’t pick on medicines in health service downturn, says ABPI’s Barker

June 18, 2009
Research and Development ASCO, Cancer

The UK's health service is heading for a severe financial shortfall and will have to consider limiting spending, including on …

News

Anti-smoking measures boosted by £2.5m grant

June 11, 2009
Cancer, NHS

Government anti-smoking measures are to receive a boost with the provision of a £2.5 million grant to help smokers kick …

News

AstraZeneca and Merck launch early stage trial collaboration

June 3, 2009
Research and Development AZ, AstraZeneca, Cancer, Merck

Merck and AstraZeneca have begun an unprecedented collaboration to bring together the clinical trials of two early stage cancer medicines.The …

News

Boost for UK cancer care services

May 8, 2009
Sales and Marketing Cancer, NHS

News

Avastin fails in colon cancer study

April 30, 2009
Research and Development Cancer, Roche

Roche's blockbuster Avastin has failed to show success in treating early-stage colon cancer. A phase III trial found Avastin (bevacizumab) …

News

Nexavar fails in melanoma study

April 30, 2009
Research and Development Bayer, Cancer, Nexavar

Onyx Pharmaceuticals and its development partner Bayer have stopped a phase II trial of Nexavar in patients with late-stage melanoma, …

News

Pfizer halts Sutent head-to-head trial

April 6, 2009
Research and Development, Sales and Marketing Cancer, Pfizer, Sutent

Pfizer has halted a late-stage breast cancer trial between Sutent and Roche's Xeloda, after the study failed to show significant …

News

Survey adds pressure for re-think on bowel cancer drugs

March 24, 2009
Medical Communications, Sales and Marketing Cancer

A new survey by Beating Bowel Cancer has highlighted the problems facing patients with the condition in getting the best …

News

Positive results halt Avastin-Tarceva trial

February 16, 2009
Sales and Marketing Cancer, Roche, avastin

A phase III trial has been stopped early after promising results for Avastin and Tarceva combined as first-line maintenance treatment …

News

GSK hopeful of NICE approval for Tyverb

January 26, 2009
Sales and Marketing Cancer, GSK, breast cancer

NICE could be poised to reverse its rejection of GSK's breast cancer treatment Tyverb, the pharma company has said.NICE rejected …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026